Marshall Wace’s Adverum Biotechnologies ADVM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $107K | Buy |
+49,628
| New | +$107K | ﹤0.01% | 2387 |
|
|
2025
Q1 | – | Sell |
-98,027
| Closed | -$458K | – | 2438 |
|
|
2024
Q4 | $458K | Buy |
98,027
+55,130
| +129% | +$257K | ﹤0.01% | 1928 |
|
|
2024
Q3 | $301K | Sell |
42,897
-161,722
| -79% | -$1.14M | ﹤0.01% | 1982 |
|
|
2024
Q2 | $1.4M | Buy |
204,619
+70,768
| +53% | +$485K | ﹤0.01% | 1394 |
|
|
2024
Q1 | $1.89M | Buy |
+133,851
| New | +$1.89M | ﹤0.01% | 1216 |
|
|
2023
Q4 | – | Sell |
-237,331
| Closed | -$356K | – | 1790 |
|
|
2023
Q3 | $356K | Buy |
+237,331
| New | +$356K | ﹤0.01% | 1531 |
|
|
2023
Q1 | – | Sell |
-341,397
| Closed | -$198K | – | 2080 |
|
|
2022
Q4 | $198K | Sell |
341,397
-164,340
| -32% | -$95.3K | ﹤0.01% | 2114 |
|
|
2022
Q3 | $481K | Buy |
+505,737
| New | +$481K | ﹤0.01% | 2061 |
|
|
2022
Q1 | – | Sell |
-206,022
| Closed | -$364K | – | 2547 |
|
|
2021
Q4 | $364K | Buy |
+206,022
| New | +$364K | ﹤0.01% | 2295 |
|
|
2021
Q1 | – | Sell |
-358,166
| Closed | -$3.88M | – | 2065 |
|
|
2020
Q4 | $3.88M | Sell |
358,166
-11,550
| -3% | -$125K | 0.02% | 612 |
|
|
2020
Q3 | $3.81M | Buy |
+369,716
| New | +$3.81M | 0.02% | 576 |
|
|
2014
Q4 | – | Sell |
-45,412
| Closed | -$1.55M | – | 790 |
|
|
2014
Q3 | $1.55M | Buy |
+45,412
| New | +$1.55M | 0.02% | 487 |
|